Chaudhry, MamoonahAlessandrini, MarcoPepper, Michael Sean2017-05-312017-05-312016-06Chaudhry, M, Alessandrini, M & Pepper, MS 2016, 'Pharmacogenomics for infectious diseases in sub-Saharan Africa : successes and opportunities', Applied & Translational Genomics, vol. 9, pp. 3-5.2212-066110.1016/j.atg.2016.04.001http://hdl.handle.net/2263/60715The rate of mortality in developing countries due to communicable disease remains alarmingly high. The leading contributors to disease burden in these regions are the so-called “big three”, namely HIV/ AIDS, TB, and malaria. The global prevalence of these diseases is over 250 million, and it should be noted that 71%, 28% and 88% of these cases, respectively, occur in sub-Saharan Africa alone (World Health Organization). African countries are continuously struggling to contain infectious diseases, and there is a need for governments to commit resources not only for treatment, but also towards research and development aimed at innovative approaches.en© 2016 Elsevier B.V. This is an open access article under the CC BY-NC-ND license.MortalityDiseaseTreatmentPharmacogenomicsInfectious diseasesSub-Saharan AfricaArticle